Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

4275 ARTíCULOS , VIENDO DEL 4171 AL 4185

PUBMED

Importance of psychiatric examination in predictive genetic testing for Huntington disease.

Uhrová T, Zidovská J, Koblihová J, Klempíř J, Majerová V, Roth J.

Neurol Neurochir Pol. 2013 Nov-Dec;47(6):534-41.

0

0

0

PUBMED

Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease.

Cox CJ, Sharma M, Leckman JF, Zuccolo J, Zuccolo A, Kovoor A, Swedo SE, Cunningham MW.

J Immunol. 2013 Dec 1;191(11):5524-41. doi: 10.4049/jimmunol.1102592.

0

0

0

PUBMED

Tapping linked to function and structure in premanifest and symptomatic Huntington disease.

Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJ, Jauffret C, Say MJ, Sturrock A, Johnson H, Onorato CE, Salat DH, Durr A, Leavitt BR, Roos RA, Landwehrmeyer GB, Langbehn DR, Stout JC, T

Neurology. 2010 Dec 14;75(24):2150-60. doi: 10.1212/WNL.0b013e3182020123.

0

0

0

PUBMED

Glutathione peroxidase activity is neuroprotective in models of Huntington's disease.

Mason RP, Casu M, Butler N, Breda C, Campesan S, Clapp J, Green EW, Dhulkhed D, Kyriacou CP, Giorgini F.

Nat Genet. 2013 Oct;45(10):1249-54. doi: 10.1038/ng.2732.

0

0

0

PUBMED

Objective acoustic quantification of phonatory dysfunction in Huntington's disease.

Rusz J, Klempíř J, Baborová E, Tykalová T, Majerová V, Cmejla R, Růžička E, Roth J.

PLoS One. 2013 Jun 10;8(6):e65881. doi: 10.1371/journal.pone.0065881. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/a1ee87ea-1fdb-4baa-a8b0-62a44342f3cc.

0

0

0

PUBMED

Music perception and movement deterioration in Huntington's disease.

Beste C, Schüttke A, Pfleiderer B, Saft C.

PLoS Curr. 2011 Sep 20;3:RRN1252. doi: 10.1371/currents.RRN1252.

0

0

0

PUBMED

Treating mouse models of Huntington disease.

Tallaksen-Greene SJ, Albin RL.

Neuropsychopharmacology. 2011 Nov;36(12):2373-4. doi: 10.1038/npp.2011.158. No abstract available.

0

0

0

PUBMED

Huntington's disease presenting as posterior cortical atrophy.

Caixeta L.

Arq Neuropsiquiatr. 2011;69(2B):407-8. No abstract available.

0

0

0

PUBMED

The mechanism of degeneration of striatal neuronal subtypes in Huntington disease.

Rikani AA, Choudhry Z, Choudhry AM, Rizvi N, Ikram H, Mobassarah NJ, Tulli S.

Ann Neurosci. 2014 Jul;21(3):112-4. doi: 10.5214/ans.0972.7531.210308. Review.

0

0

0

PUBMED

General Anesthesia for Dental Treatment in a Patient With Huntington's Chorea.

Haimov-Kaldess I, Haim D, Garfunkel A.

Compend Contin Educ Dent. 2016 Jan;37(1):22-5; quiz 26.

0

0

0

PUBMED

Huntington's disease is a four-repeat tauopathy with tau nuclear rods.

Fernández-Nogales M, Cabrera JR, Santos-Galindo M, Hoozemans JJ, Ferrer I, Rozemuller AJ, Hernández F, Avila J, Lucas JJ.

Nat Med. 2014 Aug;20(8):881-5. doi: 10.1038/nm.3617.

0

0

0

PUBMED

A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles.

Southwell AL, Skotte NH, Villanueva EB, Østergaard ME, Gu X, Kordasiewicz HB, Kay C, Cheung D, Xie Y, Waltl S, Dal Cengio L, Findlay-Black H, Doty CN, Petoukhov E, Iworima D, Slama R, Ooi J, Pouladi M

Hum Mol Genet. 2017 Jan 18. pii: ddx021. doi: 10.1093/hmg/ddx021. [Epub ahead of print]

0

0

0

PUBMED

Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.

Rüb U, Hentschel M, Stratmann K, Brunt E, Heinsen H, Seidel K, Bouzrou M, Auburger G, Paulson H, Vonsattel JP, Lange H, Korf HW, den Dunnen W.

Brain Pathol. 2014 Apr;24(3):247-60. doi: 10.1111/bpa.12115.

0

0

0

PUBMED

Feasibility of computerized working memory training in individuals with Huntington disease.

Sadeghi M, Barlow-Krelina E, Gibbons C, Shaikh KT, Fung WLA, Meschino WS, Till C.

PLoS One. 2017 Apr 28;12(4):e0176429. doi: 10.1371/journal.pone.0176429. eCollection 2017.

0

0

0

PUBMED

Dysregulated brain creatine kinase is associated with hearing impairment in mouse models of Huntington disease.

Lin YS, Chen CM, Soong BW, Wu YR, Chen HM, Yeh WY, Wu DR, Lin YJ, Poon PW, Cheng ML, Wang CH, Chern Y.

J Clin Invest. 2011 Apr;121(4):1519-23. doi: 10.1172/JCI43220.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy